| pubmed-article:2651685 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2651685 | lifeskim:mentions | umls-concept:C0003232 | lld:lifeskim |
| pubmed-article:2651685 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:2651685 | lifeskim:mentions | umls-concept:C0041740 | lld:lifeskim |
| pubmed-article:2651685 | lifeskim:mentions | umls-concept:C0006819 | lld:lifeskim |
| pubmed-article:2651685 | lifeskim:mentions | umls-concept:C0085510 | lld:lifeskim |
| pubmed-article:2651685 | lifeskim:mentions | umls-concept:C0312418 | lld:lifeskim |
| pubmed-article:2651685 | lifeskim:mentions | umls-concept:C0205409 | lld:lifeskim |
| pubmed-article:2651685 | lifeskim:mentions | umls-concept:C0020027 | lld:lifeskim |
| pubmed-article:2651685 | lifeskim:mentions | umls-concept:C0036667 | lld:lifeskim |
| pubmed-article:2651685 | lifeskim:mentions | umls-concept:C0028075 | lld:lifeskim |
| pubmed-article:2651685 | lifeskim:mentions | umls-concept:C1880022 | lld:lifeskim |
| pubmed-article:2651685 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:2651685 | pubmed:dateCreated | 1989-6-2 | lld:pubmed |
| pubmed-article:2651685 | pubmed:abstractText | One hundred and thirteen rectal swabs and 87 faecal samples obtained from the Paediatric casualty of the Lagos University Teaching Hospital, Lagos, Nigeria were processed for Campylobacter jejuni/coli. Twenty-two (11%) of the specimens were positive for C. jejuni. Biotyping results showed that nine (41%) and eight (36%) belonged to C. jejuni biotypes I and II respectively, while three (14%) and two (9%) belonged to C. coli biotypes I and II. Serotyping results revealed that C. jejuni biotypes I and II and C. coli biotypes I and II belonged to different serotypes with serotypes A9 and A36 being the most prevalent. In-vitro antibiotic sensitivity testing using the disc method showed that 18 (82%) of the Campylobacter jejuni/coli isolates were sensitive to erythromycin and nalidixic acid, while 16 (73%) were sensitive to streptomycin. All were resistant to penicillin, while four (18%) and six (27%) were sensitive to tetracycline and cloxacillin respectively. We therefore recommend the use of erythromycin and streptomycin for cases of Campylobacter enteritis requiring antimicrobial therapy in Lagos, Nigeria. | lld:pubmed |
| pubmed-article:2651685 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2651685 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2651685 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2651685 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2651685 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2651685 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2651685 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2651685 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2651685 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:2651685 | pubmed:issn | 0022-5304 | lld:pubmed |
| pubmed-article:2651685 | pubmed:author | pubmed-author:CokerA OAO | lld:pubmed |
| pubmed-article:2651685 | pubmed:author | pubmed-author:ObiC LCL | lld:pubmed |
| pubmed-article:2651685 | pubmed:author | pubmed-author:AlabiS ASA | lld:pubmed |
| pubmed-article:2651685 | pubmed:author | pubmed-author:OlaiyaBB | lld:pubmed |
| pubmed-article:2651685 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2651685 | pubmed:volume | 92 | lld:pubmed |
| pubmed-article:2651685 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2651685 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2651685 | pubmed:pagination | 104-7 | lld:pubmed |
| pubmed-article:2651685 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:meshHeading | pubmed-meshheading:2651685-... | lld:pubmed |
| pubmed-article:2651685 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2651685 | pubmed:articleTitle | Characterization and antibiotic sensitivity of Campylobacter jejuni and Campylobacter coli isolated from children at the Lagos University Teaching Hospital (LUTH), Lagos, Nigeria. | lld:pubmed |
| pubmed-article:2651685 | pubmed:affiliation | Department of Medical Microbiology and Parasitology, College of Medicine, University of Lagos, Nigeria. | lld:pubmed |
| pubmed-article:2651685 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2651685 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
